HC Biologics is pleased to announce its participation in the 35th National Turkish Orthopedics and Traumatology Congress (TOTBİD 2026), taking place from November 3–8, 2026, at the Sueno Belek Convention Center in Antalya, Türkiye.
This major scientific meeting brings together orthopedic and traumatology specialists to exchange knowledge, explore advances in clinical practice, and discuss the future of musculoskeletal care. Under the theme “From Registry to Evidence: Data-Driven Transformation in Orthopaedics and Traumatology,” the congress highlights the role of clinical data, scientific evidence, and emerging technologies in advancing patient care.
HC Biologics is committed to supporting healthcare professionals through innovative biologic solutions and technologies designed to meet evolving clinical needs. The congress provides an opportunity to connect with orthopedic surgeons, healthcare professionals, and industry partners while exploring opportunities for collaboration and distribution.
Learn more about the congress and connect with HC Biologics to discover our portfolio and explore potential partnerships.
TOTBİD 2026 | 35th National Turkish Orthopedics and Traumatology Congress
Sueno Belek Convention Center | Antalya, Türkiye
HC Biologics is pleased to participate in EUROSPINE 2026, October 7–9 in Gothenburg, Sweden.
HC Biologics will participate in Medical Fair Asia 2026, September 9–11 at Marina Bay Sands, Singapore.
This global event offers valuable opportunities to connect with healthcare professionals.
During the meeting, HC Biologics will showcase its advanced portfolio of solutions.